{"id":1495,"date":"2018-04-07T16:19:42","date_gmt":"2018-04-07T21:19:42","guid":{"rendered":"https:\/\/www.illinoisinjurylawyerblog.net\/?p=1495"},"modified":"2019-06-27T12:51:08","modified_gmt":"2019-06-27T17:51:08","slug":"the-debate-over-a-controversial-clot-busting-stroke-medication","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/the-debate-over-a-controversial-clot-busting-stroke-medication\/","title":{"rendered":"The Debate Over a Controversial “Clot-Busting” Stroke Medication"},"content":{"rendered":"
\"prescription

Photo Credit: Victor Moussa \/ Shutterstock.com<\/p><\/div>\n

A stroke is essentially a \u201cbrain attack\u201d that \u2013 like a heart attack \u2013 occurs when the blood flow to a portion of the brain is cut off. Strokes are the fifth-leading cause of death in the United States, with about 800,000 people suffering from a stroke each year. It is also estimated that approximately 80% of strokes can be prevented, and even those that are not prevented may be able to have their harmful effects reduced. However, an Illinois medical malpractice case can arise when a stroke is not promptly and competently addressed.<\/p>\n

One of the ways that doctors treat a stroke in hopes of reducing its long-term effects is through medication. If medication can be provided to the patient soon enough after the stroke begins, blood may be able to be restored to the brain, reducing the chance of permanent disability or death.<\/p>\n

Over the past few years, there has been a vigorous debate over the use of one stroke medication in particular, tissue plasminogen activator (TPA). According to those in favor of TPA, the drug acts as a clot-buster, opening blocked blood vessels and allowing blood to return to the brain. A recent news article<\/a> discusses TPA, as well as the fact that despite having been around for over 20 years, it is still not commonly used to treat stroke victims.<\/p>\n

Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

A stroke is essentially a \u201cbrain attack\u201d that \u2013 like a heart attack \u2013 occurs when the blood flow to a portion of the brain is cut off. Strokes are the fifth-leading cause of death in the United States, with about 800,000 people suffering from a stroke each year. It is also estimated that approximately 80% of strokes can be prevented, and even those that are not prevented may be able to have their harmful effects reduced. However, an Illinois medical malpractice case can arise when a stroke is not promptly and competently addressed.<\/p>\n","protected":false},"author":2,"featured_media":2379,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[],"class_list":["post-1495","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-malpractice"],"yoast_head":"\nTissue Plasminogen Activator (TPA) Injury Lawyers in Chicago<\/title>\n<meta name=\"description\" content=\"Over the past few years, there has been a vigorous debate over the use of tissue plasminogen activator (TPA). Call Moll Law Group today at (312) 462-1700.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/the-debate-over-a-controversial-clot-busting-stroke-medication\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Tissue Plasminogen Activator (TPA) Injury Lawyers in Chicago\" \/>\n<meta name=\"twitter:description\" content=\"Over the past few years, there has been a vigorous debate over the use of tissue plasminogen activator (TPA). Call Moll Law Group today at (312) 462-1700.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2018\/04\/Victor-Moussa.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tissue Plasminogen Activator (TPA) Injury Lawyers in Chicago","description":"Over the past few years, there has been a vigorous debate over the use of tissue plasminogen activator (TPA). Call Moll Law Group today at (312) 462-1700.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/the-debate-over-a-controversial-clot-busting-stroke-medication\/","twitter_card":"summary_large_image","twitter_title":"Tissue Plasminogen Activator (TPA) Injury Lawyers in Chicago","twitter_description":"Over the past few years, there has been a vigorous debate over the use of tissue plasminogen activator (TPA). Call Moll Law Group today at (312) 462-1700.","twitter_image":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2018\/04\/Victor-Moussa.jpg","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.molllawgroup.com\/blog\/the-debate-over-a-controversial-clot-busting-stroke-medication\/#article","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/the-debate-over-a-controversial-clot-busting-stroke-medication\/"},"author":{"name":"Moll Law Group","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"headline":"The Debate Over a Controversial “Clot-Busting” Stroke Medication","datePublished":"2018-04-07T21:19:42+00:00","dateModified":"2019-06-27T17:51:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/the-debate-over-a-controversial-clot-busting-stroke-medication\/"},"wordCount":657,"image":{"@id":"https:\/\/www.molllawgroup.com\/blog\/the-debate-over-a-controversial-clot-busting-stroke-medication\/#primaryimage"},"thumbnailUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2018\/04\/Victor-Moussa.jpg","articleSection":["Medical Malpractice"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/the-debate-over-a-controversial-clot-busting-stroke-medication\/","url":"https:\/\/www.molllawgroup.com\/blog\/the-debate-over-a-controversial-clot-busting-stroke-medication\/","name":"Tissue Plasminogen Activator (TPA) Injury Lawyers in Chicago","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/the-debate-over-a-controversial-clot-busting-stroke-medication\/#primaryimage"},"image":{"@id":"https:\/\/www.molllawgroup.com\/blog\/the-debate-over-a-controversial-clot-busting-stroke-medication\/#primaryimage"},"thumbnailUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2018\/04\/Victor-Moussa.jpg","datePublished":"2018-04-07T21:19:42+00:00","dateModified":"2019-06-27T17:51:08+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"Over the past few years, there has been a vigorous debate over the use of tissue plasminogen activator (TPA). Call Moll Law Group today at (312) 462-1700.","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/the-debate-over-a-controversial-clot-busting-stroke-medication\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/the-debate-over-a-controversial-clot-busting-stroke-medication\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.molllawgroup.com\/blog\/the-debate-over-a-controversial-clot-busting-stroke-medication\/#primaryimage","url":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2018\/04\/Victor-Moussa.jpg","contentUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2018\/04\/Victor-Moussa.jpg","width":4288,"height":2848,"caption":"Photo Credit: Victor Moussa \/ Shutterstock.com"},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/the-debate-over-a-controversial-clot-busting-stroke-medication\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"The Debate Over a Controversial “Clot-Busting” Stroke Medication"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2018\/04\/Victor-Moussa.jpg","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/1495","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=1495"}],"version-history":[{"count":5,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/1495\/revisions"}],"predecessor-version":[{"id":2459,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/1495\/revisions\/2459"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media\/2379"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=1495"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=1495"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=1495"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}